Suppr超能文献

甲状腺功能在体外受精控制性卵巢超排卵过程中的变化。

Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.

机构信息

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

出版信息

Fertil Steril. 2012 Mar;97(3):585-91. doi: 10.1016/j.fertnstert.2011.12.023. Epub 2012 Jan 18.

Abstract

OBJECTIVE

To determine the exact nature and timing of alterations in thyroid function throughout controlled ovarian hyperstimulation (COH).

DESIGN

Prospective cohort study.

SETTING

University fertility clinic.

PATIENT(S): Fifty-seven women undergoing COH as part of planned in vitro fertilization.

INTERVENTION(S): None.

MAIN OUTCOME MEASURE(S): Timing and magnitude of change in serum thyroid hormones, including TSH, total and free T(4), E(2), and thyroxine-binding globulin (TBG), measured at six time points from before stimulation to 2 weeks after serum pregnancy test.

RESULT(S): Geometric mean serum TSH increased during stimulation, peaking 1 week after hCG administration compared with baseline (2.44 vs. 1.42 mIU/L), as did free T(4) (1.52 vs. 1.38 ng/dL) and TBG (32.86 vs. 21.52 μg/mL). Estradiol levels increased, peaking at hCG administration (1743.21 vs. 71.37 pg/mL). Of 50 women with baseline TSH ≤ 2.5 mIU/L, 22 (44.0%) had a subsequent rise in TSH to >2.5 during or after COH. The pattern of change over time in TSH concentrations was significantly influenced by baseline hypothyroidism and whether pregnancy was achieved.

CONCLUSION(S): COH led to significant elevations in TSH, often above pregnancy appropriate targets. These findings were particularly evident in women with preexisting hypothyroidism and may have important clinical implications for screening and thyroid hormone supplementation.

摘要

目的

确定甲状腺功能在控制性卵巢过度刺激(COH)过程中的确切变化性质和时间。

设计

前瞻性队列研究。

地点

大学生育诊所。

患者

57 名接受 COH 作为计划体外受精一部分的女性。

干预

无。

主要观察指标

在刺激前至血清妊娠试验后 2 周的 6 个时间点测量血清甲状腺激素(包括 TSH、总 T4、游离 T4、E2 和甲状腺素结合球蛋白(TBG))的时间和变化幅度。

结果

在刺激期间,血清 TSH 的几何平均浓度增加,在 hCG 给药后 1 周达到峰值,与基线相比(2.44 vs. 1.42 mIU/L),游离 T4(1.52 vs. 1.38 ng/dL)和 TBG(32.86 vs. 21.52 μg/mL)也增加。雌二醇水平升高,在 hCG 给药时达到峰值(1743.21 vs. 71.37 pg/mL)。在基线 TSH≤2.5 mIU/L 的 50 名女性中,有 22 名(44.0%)在 COH 期间或之后 TSH 随后升高至>2.5 mIU/L。TSH 浓度随时间变化的模式受基线甲状腺功能减退症和是否怀孕的显著影响。

结论

COH 导致 TSH 显著升高,通常高于妊娠适当目标。这些发现在患有先前存在的甲状腺功能减退症的女性中尤为明显,可能对筛查和甲状腺激素补充具有重要的临床意义。

相似文献

1
Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization.
Fertil Steril. 2012 Mar;97(3):585-91. doi: 10.1016/j.fertnstert.2011.12.023. Epub 2012 Jan 18.
4
Thyroid axis dysregulation during in vitro fertilization in hypothyroid-treated patients.
Thyroid. 2014 Nov;24(11):1650-5. doi: 10.1089/thy.2014.0088. Epub 2014 Sep 5.
5
THE LONG-TERM IMPACT OF CONTROLLED OVARIAN HYPERSTIMULATION ON THYROID FUNCTION.
Endocr Pract. 2016 Apr;22(4):389-95. doi: 10.4158/EP15933.OR. Epub 2015 Nov 17.
6
Levothyroxine may not adequately prepare hypothyroid women for controlled ovarian hyperstimulation.
Aust N Z J Obstet Gynaecol. 2025 Feb;65(1):121-127. doi: 10.1111/ajo.13854. Epub 2024 Jun 24.
7
Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease.
Thyroid. 2013 Oct;23(10):1312-8. doi: 10.1089/thy.2013.0022. Epub 2013 Jul 25.
8
Incidence of elevation of serum thyroid-stimulating hormone during controlled ovarian hyperstimulation for in vitro fertilization.
Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:53-7. doi: 10.1016/j.ejogrb.2013.11.003. Epub 2013 Nov 9.
9
Effects of controlled ovarian stimulation on thyroid stimulating hormone in infertile women.
Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:207-212. doi: 10.1016/j.ejogrb.2019.01.025. Epub 2019 Jan 30.

引用本文的文献

1
Importance of iodide sufficiency and normal thyroid function in fertility and during gestation.
Thyroid Res. 2025 May 27;18(1):22. doi: 10.1186/s13044-025-00235-w.
5
Effect of a High Estrogen Level in Early Pregnancy on the Development and Behavior of Marmoset Offspring.
ACS Omega. 2022 Oct 4;7(41):36175-36183. doi: 10.1021/acsomega.2c03263. eCollection 2022 Oct 18.
6
Offspring conceived through ART have normal thyroid function in adolescence and as young adults.
Hum Reprod. 2022 Jun 30;37(7):1572-1580. doi: 10.1093/humrep/deac095.
7
The Relationships among Plasma Fetuin-B, Thyroid Autoimmunity, and Fertilization Rate In Vitro Fertilization and Embryo Transfer.
Int J Endocrinol. 2022 Mar 16;2022:9961253. doi: 10.1155/2022/9961253. eCollection 2022.
8
Understanding the Pathogenesis of Gestational Hypothyroidism.
Front Endocrinol (Lausanne). 2021 May 25;12:653407. doi: 10.3389/fendo.2021.653407. eCollection 2021.

本文引用的文献

3
Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy.
J Clin Endocrinol Metab. 2010 Apr;95(4):1699-707. doi: 10.1210/jc.2009-2009. Epub 2010 Feb 3.
4
Controversies surrounding pregnancy, maternal thyroid status, and fetal outcome.
Thyroid. 2009 Apr;19(4):323-6. doi: 10.1089/thy.2009.1570.
6
The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism.
Am J Obstet Gynecol. 2009 Mar;200(3):267.e1-7. doi: 10.1016/j.ajog.2008.10.035. Epub 2008 Dec 27.
7
Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis.
Eur J Endocrinol. 2008 Jun;158(6):841-51. doi: 10.1530/EJE-07-0882.
8
Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab. 2007 Aug;92(8 Suppl):S1-47. doi: 10.1210/jc.2007-0141.
9
ACOG Committee Opinion No. 381: Subclinical hypothyroidism in pregnancy.
Obstet Gynecol. 2007 Oct;110(4):959-60. doi: 10.1097/01.AOG.0000263932.05511.d4.
10
Detection of thyroid dysfunction in early pregnancy: Universal screening or targeted high-risk case finding?
J Clin Endocrinol Metab. 2007 Jan;92(1):203-7. doi: 10.1210/jc.2006-1748. Epub 2006 Oct 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验